◼ Archived
Business
AbbVie’s next-gen Crohn’s disease combo beats Skyrizi in phase 2 trial
AbbVie presents phase 2 trial data for its next-generation Crohn's disease therapy, ABBV-466.
Crohn
2 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Health
🔮 holds
Single-cell RNA sequencing of terminal ileal biopsies identifies signatures of Crohn’s disease pathogenesis
12 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.